General Motors
BP
Ford Motor Company
AstraZeneca
DaimlerChrysler
CNN
General Electric
US Senate
Credit Suisse First Boston
Volkswagen
Siemens
Philip Morris
Bloomberg
Henkel
Verizon
Sun Microsystems
AT&T
FIAT
AstraZeneca
Nestle
General Dynamics
Hewlett Packard
ABN Amro
UBS Warburg
Merrill Lynch
New York Stock Exchange
General Motors
Philips
The Economist
France Telecom
Boeing
Lafarge
Danske Bank
Nestle
Safeway
People's Republic of China's
Ministry of Agriculture
Nordea
BP
Tesco
Pfizer
Philips
Sybase
Sprint
New York Life Insurance
US Department of Defense
Canon USA
Novell
MOL
Ingersoll-Rand
Ericsson
UK Department of Trade & Industry
EDS
Philip Morris International
Royal & SunAlliance
Novartis
Credit Lyonnais
Sun Microsystems
British American Tobacco
Norsk Hydro
AstraZeneca
Skanska
US State Department
BAE Systems
Kodak
The Royal Mail Group
Henkel
Bank of Montreal
Danske Bank
BMW
Kronos Corporation
Fujitsu Technology Services
Zurich Financial Services
Halliburton
BBC
Blue Cross/Blue Shield of Massachusetts
T-Mobile
3
UK Department of Trade & Industry
Channel 4 Corporation
VHA
Burges Salmon
General Motors
Motorola
British Telecom
Ferrari
Deloitte & Touche
PA Consulting
US Army
UK Department of Trade & Industry
EMC Corporation
BBC
US Department of Commerce
Encana Corporation
Ericsson
IEEE
Hewitt Associates LLC
BP
HEALTHvision
Lloyds
Paramount
Lexmark
US State Department
US Department of Defense
HM Revenue & Customs
JD Edwards
Nestle
Ingersoll-Rand
PricewaterhouseCoopers
3
Sun Microsystems
Vodafone Omnitel
T-Mobile
Nomura
Macmillan Publishing
Britvic Softdrinks
US State Department
Philips
Reed Elsevier
Dow Chemical Company
BBC
Siemens Power Generation
US State Department
Nestle
Texas Instruments
AstraZeneca
3
Forrester Research
Sun Microsystems
Credit Lyonnais
McData
Wall Street Journal
AstraZeneca
Lloyds
US Department of Commerce
NASA
AstraZeneca
SCA
ABN Amro
Reuters
ITN
AstraZeneca
IBM NICA
BP
Forbes.com
Nissan North America, Inc.
Toyota Motor
The McGraw-Hill Companies
Fox Sports
Society of Petroleum Engineers
US Department of Energy
AstraZeneca
European Commission
Telecom Italia
Harrah's
AXA
Sybase
Royal & SunAlliance
Napster
Oracle
Compuware
Olympus
ARM
Taylor & Francis
Federal Express
Nissan Motor
Milward Brown Precis
Federal Government of Canada
Philips
UK Home Office
HM Revenue & Customs
Lloyds
New York Life Insurance
3
Harvard Business School
Britvic Softdrinks
MOL
Macmillan Publishing
Allianz Life Insurance Co
The McGraw-Hill Companies
Philips
Vodafone Omnitel
AT&T
3
Swiss Army
Hewlett Packard
Parliament of Singapore
Pfizer
General Motors
AT&T
VMS
Singapore Police Force
Ericsson
Sony Music
General Motors
GSA Advantage!
Kaiser Permanente
Stanford Business School
Siemens
Johns Hopkins
Wachovia
Standard Life Insurance
Raytheon
US Department of Defense
Commerzbank
Allstate Insurance
State of Washington
Napa Valley County
Texas Department of Transportation
American HomePatient
TIBCO
3
Sharper Image
Xerox
Hewlett Packard
America Online
3
Lockheed Northrop Grumman
Dow Chemical Company
Draeger Medical
Sutter Health
Swiss Army
Kenyan AIDS Clinic
Nestle
Siemens
General Electric
University of Washington
Lloyds
State of Minnesota
World Wildlife Fund
Autonomy Group Customers
 
News
Events
RSS Feeds
Press Release Archives
For Financial News, please see the Investors section of the website.

News VERITY ANNOUNCES TOP... | ROCHE DIAGNOSTICS CH... | SOCIETY OF PETROLEUM...
Press Release
Related Events
Related Case Studies
Related Resources

Roche Diagnostics Chooses Verity Software To Power New Global Information Portal

Verity delivers advanced search and intelligent classification software for Roche Diagnostics employees worldwide

SUNNYVALE, CA. - 2001-11-13 - A global healthcare company has found a way to overcome the logistical and linguistic hurdles of deploying a corporate intranet. Verity, Inc. (Nasdaq: VRTY), a leading provider of infrastructure software that powers enter-prise and e-commerce portals as well as e-business applications, today announced that Roche Diagnostics, the global market leader in diagnostics prod-ucts, has licensed Verity's advanced portal infrastructure software for the Roche Diagnostics' global intranet. The Verity software will allow Roche Diagnostics employees around the world to search for and share information quickly and easily. Roche Diagnostics is a division of pharmaceutical supplier Roche, of Basel, Switzerland.

"Roche Diagnostics relies on a complex communications network to connect representatives in 47 countries, and we need a reliable means of gathering information scattered among all of our locations," said Dr. Horst Baumgarten, director of information management for Roche Diagnostics. "Through our intranet, Verity's advanced search, classification and cate-gorization software will give us a single point of access for retrieving and organizing documents created in different formats. Verity's software will allow our employees to spend much less time looking for information and more time creating innovative healthcare technologies and services."

Roche Diagnostics develops and produces diagnostics equipment for patient care, health management systems, and Nobel Prize-winning molecular systems, and also manufactures chemicals for medicines. The Roche Diagnostics intranet contains hundreds of homepages and applications that include a vast amount of information about products in development or on the market. Verity's advanced software will allow users to search for documents residing in repositories throughout Roche Diagnostics.

Verity's classification technology can organize informa-tion either automatically or based on rules set by Roche Diagnostics' administrators. This allows for maximum accuracy of search results across the broadest array of information repositories. For more efficient navigation through those repositories, Verity software also eliminates redundant files. In addition, Verity software is highly scalable. So as the numbers of users and documents grows, the Roche Diagnostics intranet can continue to deliver results to any locality without degradations to speed or accuracy.

"Roche Diagnostics' global information-sharing challenge is not new to Verity," said Anthony J. Bettencourt, president of Verity. "We are experts at simplifying complex issues such as making vast amounts of disparate corporate information available to any authorized user in any location. Roche Diagnostics' success is built on the intellectual capital of its employees around the world. Verity software helps turn that intellectual capital into a competitive advantage by making it much more accessible to the people who need it, when they need it."

About Verity

Headquartered in Sunnyvale, California, Verity is a leading provider of business portal infrastructure software. Verity software gives businesses a multitude of ways to improve access to vital information and perform a range of e-business operations, while enhanc-ing user experience. Verity-powered business portals, which include corporate portals used for sharing information within an enterprise; e-commerce portals for online selling; and market exchange portals for B2B activities, all provide per-sonalized informa-tion to employees, partners, customers and suppliers. In addition, most leading software vendors, as part of their e-business applications, utilize Verity technology.

Verity products are used by 80 percent of the Fortune 50 and by more than 1,000 corpo-rations in various markets. Customers include Adobe Systems, American Greetings, AT&T, Caps Gemini Ernst & Young, Cisco, CNET, Compaq, Dow Jones, EDGAR Online, Fair-Market, Financial Times, Globe and Mail, Home Depot, Lotus, NewsEdge Corporation, SAP, Siemens, Sybase, Time New Media and Timex.

For more information, contact Verity at info@verity.com or at World Wide Web site http://www.verity.com or call 408-541-1500.

About Roche and Roche Diagnostics

Headquartered in Basel, Switzerland, Roche is one of the world's leading research-oriented healthcare groups in the fields of pharmaceuticals, diagnostics and vitamins. Roche's products and services address prevention, diagnosis and treatment of diseases, thus enhancing well-being and quality of life. Roche's Diagnostics Division, the world leader in vitro diagnostics with a unique and broad product portfolio, supplies a wide array of innovative testing products and services to researchers, physicians, patients, hospitals and laboratories worldwide. Roche's website is located at www.roche.com

This press release contains forward-looking statements relating to Verity and the expected performance of its software in the Roche Diagnostics global intranet. Actual results are subject to risks and uncertainties including the risk that integration of the Verity software into the Roche Diagnostics intranet will be delayed or not occur, or not perform as anticipated, as a result of unforeseen technical difficulties. Risks relating to Verity and its products are set forth in its Form 10-K and other reports filed with the United States Securities and Exchange Commission under the caption "Risk Factors".

For more information, contact Verity at info@verity.com or at World Wide Web site http://www.verity.com or call 408-541-1500.

Verity and the Verity logo are registered trademarks or trademarks of Verity, Inc.

Channing Barringer

Edelman PR Worldwide

212-642-7716

channing.barringer@edelman.com

Winifred Shum

Verity, Inc.

408-542-2363

wshum@verity.com

This is a selection of our forthcoming events, please visit our seminars page for more information.

Automatic Hyperlinks provided by IDOL Server 7

This is a small selection of the Autonomy case studies available, please visit our publications site at http://publications.autonomy.com/ for more information.

Automatic Hyperlinks provided by IDOL Server 7

+1 415 243 9955

Company
Technology
Functionality
Products
Solutions
Services
Customers
Partners
News & Events